Results 251 to 260 of about 828,996 (313)

Development of a national consensus guideline for termination of resuscitation in the out-of-hospital environment. [PDF]

Br Paramed J
Smyth MA, Brown TP, Fothergill R, Griffiths F, Lall R, Long J, Petrou S, Siriwardena AN, Slowther AM, Bettely L, Eli K, Gardiner G, Huxley C, Khan K, Michelet F, Perkins GD.   +15 more
europepmc   +1 more source

Standalone RFID Access Control System with Data-Integrity Verification Capabilities. [PDF]

Sensors (Basel)
Popa V, Petrariu AI, Mutescu PM, Maftei AA, Lavric A.   +4 more
europepmc   +1 more source

A zero-knowledge enabled dynamic sharding architecture for scalable decentralized smart contract execution in IOT environments. [PDF]

Sci Rep
Aman K, Ur Rehman A, Masood F, Azam S, Iqbal A, Mohmand MI, Husnain G.   +6 more
europepmc   +1 more source

Correction to “Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitors”

Molecular Oncology, EarlyView.
wiley   +1 more source

Reported Cases and Deaths of National Notifiable Infectious Diseases - China, April 2026. [PDF]

China CDC Wkly
europepmc   +1 more source

RETRACTION: Mechanism of p27 Upregulation Induced by Downregulation of Cathepsin B and Upar in Glioma

Molecular Oncology, EarlyView.
RETRACTION: S. Gopinath, K. Alapati, R. R. Malla, C. S. Gondi, S. Mohanam, D. H. Dinh, and J. S. Rao, “Mechanism of p27 Upregulation Induced by Downregulation of Cathepsin B and Upar in Glioma,” Molecular Oncology 5, no. 5 (2011): 426–437, https://doi.org/10.1016/j.molonc.2011.07.004.
wiley   +1 more source

Correction to “Human papillomavirus (HPV)‐18 E6 oncoprotein interferes with the epithelial cell polarity Par3 protein”

Molecular Oncology, EarlyView.
wiley   +1 more source

RETRACTION: LncRNA NEAT1/mir-185-5p/igf2 Axis Regulates the Invasion and Migration of Colon Cancer. [PDF]

Mol Genet Genomic Med
europepmc   +1 more source

EXPRESSION OF CONCERN: DIMP53‐1: A Novel Small‐Molecule Dual Inhibitor of p53–MDM2/X Interactions with Multifunctional p53‐Dependent Anticancer Properties

Molecular Oncology, EarlyView.
wiley   +1 more source